source
- Merck's China-sourced ADC shows survival benefit in Phase 3 endometrial cancer trialMerck & Co., in partnership with Chinese biotech Kelun-Biotech, reported that its experimental antibody-drug conjugate sacituzumab tirumotecan (Sac-TMT) met its primary endpoint in a global Phase 3…
- FDA leadership overhaul follows firing of acting CDER director; 20 deaths linked to Amgen’s Tavneos in JapanThe FDA announced another leadership change, removing acting directors of its two main drug review centers. Tracy Beth Høeg, acting head of the Center for Drug Evaluation and Research (CDER), poste…